PARP1 and cancer: Since PARP1 is a promising target for precision therapy by selectively treating DNA repair-deficient cancers, the detailed examination of the underlying molecular processes of PARP1-dependent PARylation can give us a starting point to improve our methodologies and develop future therapies.